Source: Picante Today

Glaukos: Glaukos Announces Participation in September Investor Conferences

SAN CLEMENTE, Calif.-(BUSINESS WIRE)-Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to virtually participate in the following upcoming investor conferences: Wells Fargo Healthcare Conference on Thursday, September 10, 2020 at 11:00 [...]

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Thomas W Burns's photo - President & CEO of Glaukos Corp

President & CEO

Thomas W Burns

CEO Approval Rating


Glaukos is an ophthalmic medical device firm that creates micro invasive glaucoma surgery options for patients. Read more